Vaughan Nelson Investment Management L.P. Acquires New Position in Integer Holdings Corporation (NYSE:ITGR)

Vaughan Nelson Investment Management L.P. bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 282,485 shares of the medical equipment provider's stock, valued at approximately $33,337,000. Vaughan Nelson Investment Management L.P. owned approximately 0.81% of Integer at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Lee Danner & Bass Inc. acquired a new position in shares of Integer during the fourth quarter worth about $27,000. AdvisorNet Financial Inc purchased a new position in Integer in the first quarter worth approximately $28,000. Opal Wealth Advisors LLC acquired a new position in Integer during the 1st quarter worth approximately $28,000. Sterling Capital Management LLC grew its holdings in Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after acquiring an additional 279 shares in the last quarter. Finally, Principal Securities Inc. increased its position in shares of Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after purchasing an additional 152 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ITGR. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Benchmark decreased their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. KeyCorp lowered their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Finally, Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Stock Performance

Shares of Integer stock traded down $0.10 on Wednesday, hitting $118.96. The stock had a trading volume of 240,379 shares, compared to its average volume of 377,801. The stock has a market cap of $4.15 billion, a price-to-earnings ratio of 56.38, a P/E/G ratio of 1.02 and a beta of 0.98. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The company's 50 day moving average price is $119.72 and its 200 day moving average price is $127.13.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 earnings per share. On average, research analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Activity at Integer

In other news, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the sale, the director now owns 18,781 shares in the company, valued at $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director now owns 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 in the last 90 days. 2.16% of the stock is owned by insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.